Annuncio pubblicitario
Italia markets open in 3 hours 47 minutes
  • Dow Jones

    37.775,38
    +22,07 (+0,06%)
     
  • Nasdaq

    15.601,50
    -81,87 (-0,52%)
     
  • Nikkei 225

    36.818,81
    -1.260,89 (-3,31%)
     
  • EUR/USD

    1,0629
    -0,0017 (-0,16%)
     
  • Bitcoin EUR

    57.742,68
    -627,16 (-1,07%)
     
  • CMC Crypto 200

    1.258,10
    +372,56 (+39,68%)
     
  • HANG SENG

    16.069,35
    -316,52 (-1,93%)
     
  • S&P 500

    5.011,12
    -11,09 (-0,22%)
     

ResMed Announces Participation in the Bank of America Global Healthcare Conference

ResMed Inc.
ResMed Inc.

SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9:05 a.m. (British Summer Time) at the Bank of America Financial Centre in London.

More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 3 hours after the live webcast ends and will be accessible through December 13, 2022.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors
Amy Wakeham 
+1 858.836.5000
investorrelations@resmed.com

For media 
Jayme Rubenstein
+1 858.836.6798
news@resmed.com